Financial reports
20-F
2023 FY
Annual report (foreign)
31 Jan 24
20-F/A
2022 FY
Annual report (foreign) (amended)
15 May 23
20-F
2022 FY
Annual report (foreign)
1 Feb 23
20-F/A
2021 FY
Annual report (foreign) (amended)
26 Apr 22
20-F
2021 FY
Annual report (foreign)
2 Feb 22
20-F
2020 FY
Annual report (foreign)
26 Jan 21
20-F
2019 FY
Annual report (foreign)
29 Jan 20
20-F
2018 FY
Annual report (foreign)
30 Jan 19
20-F
2017 FY
Annual report (foreign)
24 Jan 18
20-F
2016 FY
Annual report (foreign)
25 Jan 17
Current reports
6-K
Current report (foreign)
31 Jan 24
6-K
Current report (foreign)
31 Jan 24
6-K
Current report (foreign)
8 Jan 24
6-K
Current report (foreign)
11 Dec 23
6-K
Current report (foreign)
5 Dec 23
6-K
Current report (foreign)
28 Nov 23
6-K
Current report (foreign)
30 Oct 23
6-K
Current report (foreign)
24 Oct 23
6-K
Current report (foreign)
4 Oct 23
6-K
Current report (foreign)
2 Oct 23
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
18 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
17 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
16 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
15 Apr 24
SC TO-T
Third party tender offer statement
11 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Feb 24
SC TO-C
Information about tender offer
6 Feb 24
SC TO-C
Information about tender offer
5 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Jan 23
Proxies
DFAN14A
Additional proxy materials by non-management
10 Jul 23
DFAN14A
Additional proxy materials by non-management
12 Jun 23
DFAN14A
Additional proxy materials by non-management
6 Nov 18
DFAN14A
Additional proxy materials by non-management
5 Nov 18
DFAN14A
Additional proxy materials by non-management
18 Oct 18
DFAN14A
Additional proxy materials by non-management
18 Oct 18
DFAN14A
Additional proxy materials by non-management
18 Oct 18
DFAN14A
Additional proxy materials by non-management
18 Oct 18
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
31 Jan 24
SD
Conflict minerals disclosure
31 May 23
UPLOAD
Letter from SEC
22 May 23
CORRESP
Correspondence with SEC
9 May 23
UPLOAD
Letter from SEC
25 Apr 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1 Feb 23
SD
Conflict minerals disclosure
31 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
2 Feb 22
SD
Conflict minerals disclosure
1 Jun 21
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
26 Jan 21
Ownership
SC 13D
MorphoSys AG
18 Apr 24
SC 13G/A
BlackRock Inc.
2 Feb 24
144
Notice of proposed sale of securities
19 Sep 23
SC 13G/A
BlackRock Inc.
1 Feb 23
3
PHARMA AG NOVARTIS
27 Jun 22
SC 13G
BlackRock Inc.
4 Feb 22
SC 13G/A
XOMA Corp
19 Aug 20
3
Cellular Biomedicine Group, Inc.
14 Aug 20
4
PHARMA AG NOVARTIS
16 Jul 20
3
PHARMA AG NOVARTIS
13 Jul 20